Racial Distribution and Management of Idiopathic Granulomatous Mastitis: A Single-Center Descriptive Cross-Sectional Study Race and Management of IGM

Niharika Singh (1), Naina Rao (2), Sourish Rathi (3), Anastasia Bakoulis (4), Patricia Farrelly (5), Brian O’Hea (6)
(1) Department of Breast Surgery, Stony Brook University Hospital, Stony Brook, New York, United States, United States,
(2) , United States,
(3) , United States,
(4) , United States,
(5) , United States,
(6) , United States

Abstract

Background: Idiopathic granulomatous mastitis (IGM) is a rare inflammatory breast disease with variable clinical manifestations. The purpose of this study is to compare racial patterns and management of IGM at a tertiary academic center in New York.


Methods: A cross-sectional study was performed on all patients with a diagnosis of IGM from 2018 to 2024 at Stony Brook University Hospital.


Results: Twenty cases of IGM were identified by chart review. Hispanic women were significantly overrepresented in women with IGM (p<0.0001). Hispanic women with IGM were significantly younger (35.1 ± 6.9 years) than white women (53.4 ± 12.2 years) at diagnosis (p=0.007) and more likely to present with clinical findings rather than radiologic findings (p=0.045). Most (71.4%) patients with no recurrence had been treated with prednisone (n=5).


Conclusion: This study suggests that a racial predilection to IGM exists. Further studies are needed to develop the most effective treatment strategy for IGM.

Full text article

Generated from XML file

References

Benson JR, Dumitru D. Idiopathic granulomatous mastitis: presentation, investigation and management. Future Oncol. 2016;12(11):1381-94. doi:10.2217/fon-2015-0038.

Dilaveri C, Degnim A, Lee C, DeSimone D, Moldoveanu D, Ghosh K. Idiopathic Granulomatous Mastitis. Breast J. 2024;2024:6693720. doi:10.1155/2024/6693720.

Xu G, Limaye S. Idiopathic granulomatous mastitis. Ann Breast Surg. 2023;7(31),1-5. doi:10.21037/abs-22.

Wang X, He X, Liu J, Zhang H, Wan H, Luo J, Yang J. Immune pathogenesis of idiopathic granulomatous mastitis: from etiology toward therapeutic approaches. Front Immunol. 2024;15:1295759. doi:10.3389/fimmu.2024.1295759.

Altintoprak F, Kivilcim T, Ozkan OV. Aetiology of idiopathic granulomatous mastitis. World J Clin Cases. 2014;2(12):852-8. doi:10.12998/wjcc.v2.i12.852.

Metanat S, Soleimani Jobaneh Y, Noori M, Sadeghi F, Mirzapour A, et al. Global Distribution of Idiopathic Granulomatous Mastitis: A Scoping Review: IGM Global Distribution. Arch Breast Cancer. 2022;9(3-SI):261-7. Available from: https://www.archbreastcancer.com/index.php/abc/article/view/563

Bhattarai P, Srinivasan A, Valenzuela CD, Sulzbach C, Wallack MK, Mariadason JG. Idiopathic granulomatous mastitis: experience at a New York hospital. Ann R Coll Surg Engl. 2022;104(7):543-7. doi: 10.1308/rcsann.2021.0239

Steuer AB, Stern MJ, Cobos G, Castilla C, Joseph KA, Pomeranz MK, et al. Clinical Characteristics and Medical Management of Idiopathic Granulomatous Mastitis. JAMA Dermatol. 2020;156(4):460-4. doi:10.1001/jamadermatol.2019.4516.

Authors

Niharika Singh
Niharika.Singh@stonybrookmedicine.edu (Primary Contact)
Naina Rao
Sourish Rathi
Anastasia Bakoulis
Patricia Farrelly
Brian O’Hea
1.
Singh N, Rao N, Rathi S, Bakoulis A, Farrelly P, O’Hea B. Racial Distribution and Management of Idiopathic Granulomatous Mastitis: A Single-Center Descriptive Cross-Sectional Study: Race and Management of IGM . Arch Breast Cancer [Internet]. [cited 2024 Dec. 11];12(1). Available from: https://archbreastcancer.com/index.php/abc/article/view/1023

Article Details